INIS
tumors
100%
interleukins
100%
genes
63%
skin
36%
metastases
36%
interferon
27%
delivery
18%
particles
18%
natural killer cells
18%
monoclonal antibodies
18%
mice
9%
levels
9%
in vivo
9%
growth
9%
comparative evaluations
9%
growth factors
9%
matrices
9%
suppression
9%
messenger-rna
9%
antibodies
9%
lungs
9%
Medicine and Dentistry
Interleukin 12
100%
Neoplasm
63%
Gene Transfer
36%
Therapeutic Procedure
36%
Skin
36%
Interferon
27%
Metastatic Carcinoma
27%
Gene Targeting
18%
Monoclonal Antibody
18%
Natural Killer Cell
18%
Cytotoxic T-Cell
18%
Complementary DNA
9%
Messenger RNA
9%
Lung Metastasis
9%
Primary Tumor
9%
Genetic Transfection
9%
Group Therapy
9%
Vasculotropin
9%
Cancer Surgery
9%
Tumor Microenvironment
9%
Antiangiogenic Activity
9%
Growth
9%
Cancer Transplantation
9%
Metastasis Inhibition
9%
Ganglioside GM1 Antibody
9%
Survival
9%
Pharmacology, Toxicology and Pharmaceutical Science
Ganglioside GM1 Antibody
9%